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ABSTRACT
The ecologically important cyanobacterium
Prochlorococcus possesses the smallest genome
among oxyphototrophs, with a reduced suite of
protein regulators and a disproportionately high
number of regulatory RNAs. Many of these are
asRNAs, raising the question whether they modulate
gene expression through the protection of mRNA
from RNase E degradation. To address this ques-
tion, we produced recombinant RNase E from
Prochlorococcus sp. MED4, which functions opti-
mally at 12mM Mg
2+, pH 9 and 35 C. RNase E
cleavage assays were performed with this recom-
binant protein to assess enzyme activity in the
presence of single- or double-stranded RNA sub-
strates. We found that extraordinarily long asRNAs
of 3.5 and 7kb protect a set of mRNAs from RNase E
degradation that accumulate during phage infec-
tion. These asRNA–mRNA duplex formations
mask single-stranded recognition sites of RNase
E, leading to increased stability of the mRNAs.
Such interactions directly modulate RNA stability
and provide an explanation for enhanced transcript
abundance of certain mRNAs during phage infec-
tion. Protection from RNase E-triggered RNA
decay may constitute a hitherto unknown regulatory
function of bacterial cis-asRNAs, impacting gene
expression.
INTRODUCTION
Endoribonuclease E (RNase E) initiates the decay of most,
if not all, mRNAs in prokaryotes by endonucleolytic
cleavage followed by polyadenylation and/or exonucleo-
lytic degradation (1). Therefore, RNase E is a crucial regu-
lator of the global rate of RNA decay. The half-life of
RNA is an important factor in the regulation of gene
expression, directly inﬂuencing the translation rates of
their encoded proteins and hence impacting the rapidity
of the response of an organism to changing environmental
conditions. Several studies have shown that stress condi-
tions, such as the presence of antibiotics, nutritional stress
and transitions in growth phase, cause a dramatic change
in the rate of RNA turnover for a subset of genes (2–4).
The presumably best characterized RNase E homologue
is that of Escherichia coli, which is organized in a multimer
enzyme complex known as the degradosome (5). The
degradosome consists of polynucleotide phosphorylase,
RNA helicase B and the glycolytic enzyme enolase (5–8).
Degradosome structures have not been identiﬁed in
cyanobacteria or spinach chloroplasts, though all compo-
nents necessary for the assembly of the degradosome
are present in cyanobacteria, including Synechocystis
PCC6803 and Prochlorococcus sp. (9–11). However,
cyanobacterial RNase E (rne) genes of the species
Synechocystis PCC6803 and Prochlorococcus sp. lack the
carboxy-terminal sequence necessary for the assembly of
the degradosome in E. coli (12). Nevertheless, similar and
important functions of RNase E in both E. coli and
Synechocystis PCC6803 can be assumed, as the disruption
of rne is lethal in both organisms (11). The role of
degradosome structures is still under debate because the
deletion of the carboxy terminus in E. coli (associated with
a loss of the degradosome structure) does not impact cell
viability (11). According to the lack of the C-terminal
extension, a feature of RNase G (Caf A family), and
sequence homology to RNase E, cyanobacterial homo-
logues have been grouped into the RNase E/G family (13).
Several recent studies have been published on whole-
transcriptome expression analyses, revealing that a signiﬁ-
cant portion of the transcriptome is expressed on the anti-
sense strand not only in Eukaryotes (14–17) but also in
Bacteria and Archaea, where data indicate that between
3% to more than half of all genes are associated with
asRNAs (18–24). In light of RNase E enzyme
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quences (25,26)—one wonders if the potential formation of
asRNA–mRNA duplexes affects RNase E activity. In this
context, in a recent microarray study on whole-genome
expression of the podovirus P-SSP7 and its cyanobacterial
host Prochlorococcus MED4, we found that transcript
abundance of 41 host genes, including RNase E, increased
during lytic infection, while the vast majority of host
mRNAs declined in abundance (27). We suggested that
the induction of host RNase E transcript may help the
phage by generating a source of nucleotides that (after
nucleotide reduction by the phage-encoded ribonucleotide
reductase) are utilized by the phage for its own replication
(27). Those results raised the question of how these 41 host
mRNAs are protected from degradation in light of the
enhanced transcription of RNase E.
Here, we set out to test the hypothesis that in the ecologic-
ally important marine cyanobacterium Prochlorococcus,
asRNA–mRNA duplex formation masks single-stranded
recognition sites of RNase E, leading to increased stability
of mRNAs and their asRNAs. Therefore, using puriﬁed
recombinant Prochlorococcus RNase E from E. coli, we
assessed RNase E activity in the presence of single- or
double-stranded RNA substrates and showed that
asRNA–mRNA duplexes protected mRNA from RNase E
degradation, enhancing mRNA stability of transcripts
accumulated during phage infection.
MATERIALS AND METHODS
Construction of rne expression plasmid pQE70PMM1501
Oligonucleotides used for PMM1501 cloning were
PMM1501_C_K12 fw and PMM1501_C_K12 rev.
Lowercase letters indicate PaeI or BamHI site
(Supplementary Table S1). Both oligonucleotides were
optimized for E. coli codon usage (Kazusa Codon Usage
Database) without impairing the PMM1501 wild-type
amino acid composition. The resulting coding sequence
of PMM1501 was cloned in pQE70 (QIAGEN, Germany).
Overexpression and puriﬁcation of recombinant RNase E
from Prochlorococcus MED4
Escherichia coli TOP10 F0 served as the host strain for
construction and propagation of pQE70-PMM1501.
Expression of recombinant PMM1501 protein was
carried out in E. coli ArcticExpress (DE3) RIL
(Stratagene, USA). Strains were grown in Luria broth,
supplemented with ampicillin (100mg/ml), streptomycin
(75mg/ml) and gentamicin (20mg/ml), if required. An over-
night culture was diluted in 2l of Luria broth and grown
at 37 Ct oa nO D 600 of 0.5–0.8. Subsequently, heter-
ologous expression was induced with isopropyl
b-D-1-thiogalactopyranoside (IPTG) (0.1mM ﬁnal con-
centration), and the culture was transferred to 10 C and
grown for an additional 48h. Thereafter, cells were har-
vested (4 C, 6000rpm, 10min) and resuspended in buffer
A [50 mM NaH2PO4, 300mM NaCl, 20mM imidazole,
(pH adjusted to 8.0 using NaOH)], containing protease
inhibitor PMSF (0.2mM). Disruption of cells was
carried out on ice by sonication. Cell debris was
removed by centrifugation at 13 000rpm for 30min at
4 C, and the supernatant was collected. C-terminally
His-tagged MED4 RNase E was puriﬁed under native
conditions by Ni
2+ nitrilotriacetic acid afﬁnity chromatog-
raphy (QIAGEN, Germany) according to the manufac-
turer’s instructions (QIAGEN handbook, ﬁfth edition).
All steps were performed at 4 C, but the pH of all
buffers was adjusted at room temperature. The Ni-NTA
matrix size was adjusted to 500ml. Following equilibra-
tion with 10 volumes of buffer A, the column was
charged with supernatant and subsequently washed with
60 volumes of buffer B [50 mM NaH2PO4, 500mM NaCl,
50mM imidazole, 0.1% (v/v) Triton X-100, 8% (v/v)
glycerol (pH adjusted to 8.0 using NaOH)]. Adsorbed
peptides were eluted by ligand exchange employing a
step gradient of 250 and 500mM imidazole in buffer con-
taining 50mM NaH2PO4, and 300mM NaCl, pH 8.0
(adjusted with NaOH). Fractions containing speciﬁc
endoribonuclease activity were identiﬁed by in vitro
assays as described below (in vitro cleavage assay) and
visualized by Coomassie-stained 10% SDS–PAA gels.
Size exclusion chromatography
Combined elution fractions of His-tag-puriﬁed MED4
RNase E were size fractionated on a superdex
20010/300GL column (GE Healthcare, Germany). The
column was equilibrated with buffer A (see puriﬁcation
of recombinant protein) and calibrated using a gel ﬁltra-
tion standard, ranging from 1.35 to 670kDa (Bio-Rad,
Germany). Fractionation was analysed and documented
with Unicorn 4.12 software (Amersham Pharmacia,
Germany).
In vitro synthesis of RNA
In vitro transcription was carried out with T7 polymerase
and PCR fragments containing a T7 recognition site as
templates using MEGAshortscript
TM High Yield
Transcription KIT (Ambion, USA), according to the
manufacturer’s instructions. Residual DNA was
removed with 2U TURBO DNase (Ambion, USA) for
15min at 37 C. RNA was puriﬁed and concentrated by
phenol–chloroform extraction and ethanol precipitation
and ﬁnally quantiﬁed using a NanoDrop ND-1000 spec-
trophotometer (PEQLAB biotechnology, Germany). Ten
micrograms of puriﬁed in vitro transcript was subjected to
electrophoretic separation on a 7M urea–6% polyacryl-
amide gel. The RNA fragment, corresponding to full-
length transcript, was excised and recovered from the gel
slice by electro-elution for 45min at 11 mA per glass tube
(Model 422 Electro-Eluter; BIO-RAD, Germany).
Enrichment of gel-puriﬁed RNA was conducted by subse-
quent gel chromatography using RNA Clean &
Concentrator
TM-25 according to the manufacturer’s in-
structions (Zymo Research, USA). If required, RNA
was treated with tobacco acid pyrophosphatase or
50-polyphosphatase (Epicentre, USA) according to the
manufacturer’s instructions and subjected to an additional
puriﬁcation by phenol–chloroform extraction and ethanol
precipitation (prior to gel puriﬁcation). The following
mRNAs and asRNAs were synthesized: PMM0684
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07411 RNA, 3kb polycistronic mRNA and 3.5kb
asRNA. Oligonucleotides used for template generation
are listed in Supplementary Table S1.
In vitro cleavage assay
For ribonuclease activity tests of duplex RNA, both
mRNA and asRNA were diluted in H2O in the same
reaction vial, heated to 95 C for 3–5min to break intrinsic
secondary and tertiary structures, and then brieﬂy chilled
on ice. The reaction mixture was complemented with
25mM Tris–HCl (pH 8.0), 60mM KCl, 5mM MgCl2,
100mM NH4Cl and 0.1mM DTT. Hybridization of com-
plementary sequence regions was carried out at room
temperature for 20min.
RNase E. In vitro cleavage was carried out for 15min at
30 Ci na5 - ml reaction mixture containing 25mM Tris–
HCl (pH 8.0), 60mM KCl, 5mM MgCl2, 100mM NH4Cl,
0.1mM DTT, 5% (w/v) glycerol, 0.2–1.3pmol ssRNA or
0.4–2.6pmol dsRNA, and 7pmol afﬁnity-puriﬁed RNase
E. Endoribonuclease activity was abolished by addition of
1ml 0.5M EDTA and 1 volume loading buffer or by direct
addition of 1 volume loading buffer. Finally, samples were
heated to 95 C for 3–5min and brieﬂy chilled on ice before
the cleavage reactions were analysed by employing elec-
trophoretic separation on 7M urea–6% polyacrylamide
gels for 2h at 6mA.
RNase III and RNase T1. Assay conditions were identical
to those of the RNase E approach, with the following
modiﬁcations. RNA digestion was carried out at 37 C
for 15min using 0.1U RNase III (Epicentre, USA; from
E. coli) and 0.5U RNase T1 (Sigma, Germany; from
Aspergillus oryzae), respectively, or according to experi-
mental requirements.
Fluorogenic cleavage assay
A ﬂuorogenic RNA oligonucleotide with a FAM tag and
a BHQ-1 quenching tag containing the RNase E recogni-
tion site of Synechocystis PCC6803 in the psbA gene
leader sequence, psbA2-50UTR [50-Phos-A-A(20-O-
Methyl)–C(20-O-Methyl)–A(20-O-Methyl)–U(FAM)–C(20-
O-Methyl)–G(20-O-Methyl)–A(20-O-Methyl)–A–A–A–U–
A–C–A–U–A–C(BHQ-1)-OH], was synthesized and
PAGE puriﬁed by Purimex (Grebenstein, Germany).
Digestion of the ﬂuorogenic oligonucleotide results in a
marked increase in ﬂuorescence that can be monitored
in real time under deﬁned reaction conditions. Cleavage
assays were carried out at 30 C in a 50-ml reaction mixture
containing 25mM Tris–HCl (pH 8.0), 60mM KCl, 5mM
MgCl2, 100mM NH4Cl, 0.1mM DTT, 5% (w/v) glycerol,
1ml afﬁnity-puriﬁed RNase E (not quantiﬁed) and 0.1mM
(in combination with MED4 RNase E) or 0.06mM (in
combination with PCC6803 RNase E) ﬂuorogenic RNA,
or adjusted according to experimental requirements. To
avoid evaporation during the course of procedure,
samples were covered with 20ml RNase-free immersion
oil. Each cleavage experiment was assayed in technical
triplicates. The cleavage reaction was monitored
continuously by ﬂuorometry using a Victor
TM X
3
multilabel plate reader (PerkinElmer; excitation at
480nm, emission at 520nm).
Growth conditions of Prochlorococcus MED4
Cells were grown at 22 C in AMP1 or Pro99 medium (28)
under 30mmolquantam
 2s
 1 continuous white cool light.
For phage infection experiments, the podovirus P-SSP7
was added at a ratio of three infective phage per cell
(MOI=3) such that the cell and phage concentrations
were 10
8cells/ml and 3 10
8 phage/ml, respectively.
Prior to phage addition, the cells were growing exponen-
tially with a generation time of 1.5 days as were the unin-
fected control cells.
RNA isolation
Total RNA was extracted from cultures using the hot
phenol method (29,30). Brieﬂy, cells were harvested by
centrifugation at 12 000rpm for 10min at 20 C. The
pellet was resuspended in RNA resuspension buffer
[10mM sodium acetate (pH 5.2), 200mM sucrose, 5mM
EDTA]. Following the addition of half a volume of
phenol, the suspension was incubated in a 60 C water
bath for 15min and subsequently incubated at room tem-
perature for another 30min. Half a volume of chloroform/
isoamyl alcohol (24:1) was added, and the homogenate
was thoroughly mixed, incubated for another 1–10min
at room temperature and centrifuged at 6000rpm
for 5min at 20 C. The upper aqueous phase was extracted
once more with one volume phenol/chloroform/
isoamyl alcohol (25:24:1) and centrifuged for 5min at
6000rpm (20 C). The aqueous phase was precipitated
with 1/10 volume 3M sodium acetate, 3 volumes 100%
ethanol and 0.2ml glycogen at  20 C overnight.
Subsequently, RNA was concentrated by centrifugation
at 13000rpm for 30min (4 C) and resuspended in
RNase-free H2O.
In vitro synthesis and labelling of RNA
Oligonucleotide probes. Ten picomoles of oligodeoxy-
nucleotide were radiolabelled at the 50-end with 10U T4
polynucleotide kinase (Fermentas, Germany), 3nmol
[g-
32P]ATP (Hartmann Analytic, Germany), 5U
RiboLock RNase inhibitor and 1 reaction buffer A
(Fermentas, Germany) in a total volume of 20ml.
Following incubation at 37 C for 30min, the reaction
was stopped by the addition of 25mM EDTA and de-
naturation at 95 C for 5min. The reaction mixture was
diluted in H2O to a total volume of 40ml and subjected to
separation on pre-packed sephadex
TM G-25 spin columns
(GE Healthcare, Germany) to remove free [g-
32P]ATP.
For probing PMM0685 mRNA or PMM0685, asRNA
oligonucleotides PMM0685 rev and PMM0685-50-
end mRNA, respectively, were used (Supplementary
Table S1).
Transcript probes. PCR fragments containing a T7 recog-
nition site were synthesized for in vitro transcription from
the T7 promoter in the presence of [a-
32P]UTP (Hartmann
4892 Nucleic Acids Research, 2011,Vol.39, No. 11Analytic, Germany) using T7 MAXIscript (Ambion,
USA). Sense and antisense probes were prepared for the
following genes: PMM0684, PMM0685, PMED4_07411,
PMED4_07431. Oligonucleotides used for template PCR
ampliﬁcation are listed in Supplementary Table S1.
Northern blot analysis
RNA samples (1.5mg total RNA or 1.3 or 2.6pmol in vitro
transcripts) were supplemented with loading buffer,
denatured at 65 C for 5min, and then brieﬂy chilled on
ice before electrophoretic separation on 7M urea–6%
polyacrylamide gels for 2h at 6mA or 1.5% formalde-
hyde–agarose or native gels for 2h at 80V, respectively.
Polyacrylamide gels were transferred to Hybond-N
nylon membranes (Amersham, Germany) by electro-
blotting for 1h at 400 mA. Agarose gels were transferred
overnight by capillary blotting using 20 SSC (3M NaCl,
0.3M sodium citrate, pH 7.0) as transfer solution.
Membranes were hybridized overnight at 42 or 57 C
with labelled oligonucleotide probes or labelled transcript
probes, respectively, in 50% deionized formamide, 7%
SDS, 250mM NaCl and 120mM Na(PO4) pH 7.2.
Membranes were washed in 2  SSC/1% SDS for
10min, in 1 SSC/0.5% SDS for another 10min and, ac-
cording to signal intensity, 1–10min in 0.1 SSC/0.1%
SDS. All wash steps were carried out at 5 C below the
hybridization temperature with pre-warmed buffers.
Membranes were exposed to imaging plates, and the re-
sulting signals were visualized using a Personal Molecular
Imager FX system with Quantity One software (Bio-Rad,
Germany).
Reverse transcription–PCR
DNA was removed from total RNA using TURBO
TM
DNase (Ambion, USA). Treatment of RNA samples
(3–15mg) was performed in three consecutive incubation
steps for 20min each at 37 C using 6 U of DNase in total.
The reaction was stopped with inactivation reagent
(Ambion, USA), and the supernatant was puriﬁed and
enriched by gel chromatography using RNA Clean &
Concentrator
TM-25 according to the manufacturer’s
instructions (Zymo Research, USA).
Reverse transcription (RT) was performed with
0.75–1.5mg total RNA using Superscript III (Invitrogen,
Germany). Brieﬂy, after denaturation at 95 C for
3–5min, a mixture containing RNA and 0.5mMo f
target- and strand-speciﬁc oligonucleotide ‘RT–mRNA’
(for ampliﬁcation of mRNA) or ‘RT–asRNA’ (for ampli-
ﬁcation of asRNA) was incubated at 42 C for 20min to
permit annealing. The mixture was complemented with
4U RiboLock RNase inhibitor (Fermentas, Germany),
1mM dNTPs, 10mM DTT, 5mM MgCl2,1  reaction
buffer (Invitrogen, Germany) and 200U reverse transcript-
ase in a total volume of 20ml. For ﬁrst-strand synthesis, the
reaction was incubated at 42 C for 2h and the enzyme
was inactivated for 5min at 95 C. cDNA was ampliﬁed
by PCR in a 50-ml reaction mixture comprising 0.2mM
oligonucleotides, 1 HF reaction buffer (Finnzymes,
USA), 1U Phusion polymerase (Finnzymes, USA) and
0.2mM dNTPs. The following thermo proﬁle was
applied: 98 C for 30s; 32 cycles of 98 C for 10s, 54 C for
30s, and 72 C for 3min; and 72 C for 5min. To amplify
cDNA derived from mRNA, the primers RT–mRNA
(reverse primer) and GI-II-mRNA (forward primer) were
used. To amplify cDNA derived from asRNA, the primers
RT–asRNA (reverse primer) and RT–mRNA (forward
primer) were used. Oligonucleotides used for RT–PCR
are listed in Supplementary Table S1. The lack of contam-
ination with genomic DNA was veriﬁed by omitting the
enzyme in an additional reverse transcription control
reaction.
RESULTS
Puriﬁcation of Prochlorococcus RNase E
Expression of recombinant Prochlorococcus MED4
RNase E (PMM1501) protein required the adjustment
of the codon usage of the ﬁrst 63nt and the last 42nt of
PMM1501 for sufﬁcient expression in E. coli. C-terminally
His-tagged pQE70-PMM1501 was overexpressed in E. coli
strain Arctic Express (DE3) RIL and puriﬁed under
native conditions by afﬁnity column chromatography.
Recombinant PMM1501 protein migrated according to
its theoretical molecular weight of 70kDa in SDS–poly-
acrylamide gels (Figure 1 and Supplementary Figure S1).
Mass spectrometry analysis of the puriﬁed protein fraction
did not reveal any contamination with E. coli-speciﬁc
RNase E protein or other host ribonucleases (data not
shown). Furthermore, western blots of the puriﬁed
protein fraction were immunodecorated with antibodies
targeting E. coli-speciﬁc RNase E, RNase R or PNPase.
None of these antibodies detected measurable amounts of
the respective target protein in the elution fraction used
for cleavage assays (Supplementary Figure S1A). To test
for the presence of other sources of E. coli-speciﬁc exo-
nuclease activity in the puriﬁed protein fraction, we
in vitro transcribed a poly-A RNA, a substrate for exo-
nucleases in general (RNase R, PNPase, RNase II) but not
for RNase E, and incubated it with RNase R or recom-
binant Prochlorococcus RNase E. Cleavage activity was
only detected with RNase R but not with recombinant
PMM1501 (Supplementary Figure S1B) verifying that
the recombinant Prochlorococcus RNase E protein was
not contaminated with nucleases from E. coli.
To assess the quaternary structure of afﬁnity-puriﬁed
pQE70-PMM1501 protein, we analysed the oligomeriza-
tion state by gel ﬁltration. According to the calibration
proﬁle, the main part of puriﬁed recombinant MED4
RNase E was eluted probably as a tetramer (Figure 1),
which would suggest a similar conformer organ-
ization as that present in E. coli and Synechocystis
PCC6803. These results are in good agreement with the
presence of the highly conserved Zn-link motif in the
Prochlorococcus RNase E sequence. Callaghan et al. (31)
demonstrated that the Zn-link is involved in the organ-
ization of a functional active quaternary structure of
RNase E/G in E. coli by mediating its dimerization and
tetramerization.
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Prochlorococcus RNase E
To establish optimal RNA cleavage conditions and to de-
termine the physicochemical properties of MED4 RNase
E, we assessed cleavage of a ﬂuorescently labelled synthet-
ic oligonucleotide substrate containing the RNase E rec-
ognition site of Synechocystis PCC6803 psbA leader (32)
(see ‘Material and Methods’ section). We found that
monovalent cations are not required whereas divalent
cations are essential for MED4 RNase E enzyme activity
with an optimum at 12mM Mg
2+ (Supplementary
Figure S2). The enzyme was active between pH 5 and
11, with optimal activity at pH 9 (Figure S2D). The
optimal temperature for enzyme activity was 35 C
(Supplementary Figure S2E), 10  above the optimal
growth temperature for Prochlorococcus MED4 (33).
Interestingly, the temperature optima for RNase E
activity from Synechocystis PCC6803 [courtesy of M.
Asayama (32)] was at 25 C (data not shown), which
grows optimally at 30 C (34,35). Similar growth-deviant
enzyme optima have been reported for puriﬁed glutamine
synthetases of Prochlorococcus PCC9511 (a clonal culture
of MED4) and Synechocystis PCC6803 with maximal
enzyme activities at 55 and 35 C, respectively (36).The
MED4 RNase E enzyme was quite stable up to 52 C,
whereas a nearly complete inhibition of the enzyme was
observed at 56 C (Supplementary Figure S2F).
Transcript organization and expression of phage
infection-induced transcripts located in genomic
island II and in the ribosomal gene cluster
A previous study on global expression proﬁles of
Prochlorococcus MED4 transcripts during phage infection
revealed the induction of a 1.5-kb region in genomic island
II consisting of three small ORFs, from PMM0684 to
PMM0686. Only PMM0686 has a proposed function
(clpS-like protease) (27). Here, we investigated the
genetic organization of this region in more detail. RT–
PCRs and northern blot analysis revealed that this
region is organized as a polycistron extending into two
upstream genes, ssrS (6S RNA, Yfr7) and PMM0683
(purK), and one downstream gene, yfr3 (Figure 2A and
B). In total, the polycistronic region encompasses 3kb
from nucleotide position 651 956–654 987, as determined
from RT–PCR data and veriﬁed by northern blot analysis
(Figure 2B and C). In another global microarray analysis,
asRNAs partially covering the complementary strand of
the same polycistronic region were identiﬁed (37).
According to RT–PCR data and northern blot analysis,
these asRNAs originate from one large precursor of 3.5kb
at nucleotide 651 469–654 987 on the complementary
strand (Figure 2B and C), leading to complete coverage
of the polycistronic region in genomic island II. Both
RNAs on the sense and antisense strand are induced or
stabilized during phage infection (Figure 2B and
Supplementary Figure S3) (27,37) supporting our hypoth-
esis that mRNA–asRNA duplex formation can protect
RNA from RNase E degradation. Similar cleavage
patterns were observed during exponential growth and
phage infection despite changes in relative accumulation
of the different bands (Figure 2B). Another region that is
induced during phage infection is that of the ribosomal
protein gene cluster. An increase of gene expression has
been measured for rps11 (PMM1536), rpl6 (PMM1544)
through rpl5 (PMM1546) and rpl16 (PMM1551) (27).
These ﬁve genes belong to two adjacent operons ranging
from PMM1533 to PMM1558 (38). Using speciﬁc primers
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4894 Nucleic Acids Research, 2011,Vol.39, No. 11in RT–PCR, we detected a 7-kb asRNA from nucleotide
1 476 365–1 483 393 that covers the complete
phage-induced region (Figure 2D and E). Notably, the
detection of a 7-kb asRNA is the ﬁrst report of a prokary-
otic asRNA with such an extraordinary length. However,
asRNAs covering more than one gene have been reported
before in the bacterium Listeria monocytogenes (39).
RNA–RNA duplex formation masks recognition sites
of RNase E
We established an in vitro RNase E cleavage assay to
follow up our initial questions about how the activation
of genes in genomic island II is regulated during phage
infection and how these RNAs are protected from degrad-
ation in light of the enhanced transcription of RNase E.
The mRNAs of four small ORFs of genomic island II
(PMM0684, PMM0685, PMED4_07411, PMED4_7431),
which were induced during phage infection (Figure 2B
and Supplementary Figure S3), were synthesized in vitro
and incubated with puriﬁed recombinant MED4 RNase
E. All four transcripts were recognized by RNase E
and were susceptible to speciﬁc cleavage (Figure 3).
RNase E and RNase III cleavage sites of PMM0685
were investigated in more detail by northern hybridization
PMED4_07451
PMED4_07431
PMM0683
PMM0684
PMED4_07411
PMM0685
PMM0686
yfr7
651469 654987
651956 654987
A
yfr3
yfr15
probe
B
C
M FW RV
as
M rps/l
11.5
4.7
2.8
1.7
1.1
0.8
0.5
0.3
GI II
kb
0.2
0.5
1
3
4
6
2
1.5
kb
as
M rps11
D
A
B
M
kb
PMED4_07411
0.2
6
0.5
1
3
4
2
1.5
A
rnpB
E
asPMED4_07411
C 14 C 14
11.5
4.7
2.8
1.7
1.1
0.8
0.5
0.3
kb
asPMED4_07411
B
PMED4_07432
C 14
Figure 2. Organization of phage-induced transcripts from genomic island II. (A) Genome arrangement and transcript organization of the section of
genomic island II starting with yfr7 (46). Protein-coding genes and non-coding RNA genes (yfr) are shown in dark-blue and light-brown boxes,
respectively. Transcript lengths as determined by RT–PCR are marked with horizontal arrows, blue for the forward strand and red for the reverse
strand. The vertical arrows correspond to the PCR primers. Black arrows indicate primary transcript starts that were determined by 454 deep
sequencing (unpublished data). Binding sites of probes used for northern hybridization shown in (B) are indicated by boxes and labelled with letter A
in blue for the forward strand or B in red for the reverse strand. (B) Expression changes of PMED4_07411 in genomic island II and its asRNA
during phage infection as determined from northern blot analysis. Lane C—RNA from uninfected control cells. Lanes 1 and 4—RNA from cells
during phage infection 1 or 4h after phage addition. Total RNA (1.5mg) was loaded per lane. A blot with higher resolution of a section of
asPMED4_07411 is presented to the right of the asRNA hybridization. As a loading control rnpB was hybridized. Transcript lengths were estimated
from Fermentas RNA high-range marker (M). Probes used for northern hybridizations are indicated by boxes labelled with letter A in blue for the
forward strand or B in red for the reverse strand. (C) RT–PCRs of genomic island II (GI II) region on the forward (fw) and reverse (rv) strand
revealing an asRNA of  3.5kb. (D) RT–PCR of the asRNA transcript of ribosomal protein cluster (asrps/l) revealing an asRNA of approximately
7kb. PCR fragment lengths were estimated from lambda PstI marker (M). The identity of cDNAs was veriﬁed by Sanger sequencing of PCR
products. (E) Northern blot hybridized with a probe targeting the antisense region of rps11. The asrps11 probe was synthesized using oligonucleotides
asrps11_FW and asrps11_RV (Supplementary Table S1). M—fermentas RNA high-range marker.
Nucleic Acids Research, 2011,Vol.39, No. 11 4895(Supplementary Figure S4) using speciﬁc oligonucleotide
probes targeting the 50- and 30-ends, respectively, of the
ribonuclease-treated transcripts. The RNase E cleavage
sites identiﬁed are listed in Table 1. All four cleavage
sites were located in loop regions, indicating that the sec-
ondary structure is more relevant than sequence speciﬁcity
for RNase E recognition (Figure 4B). RNase III cleavage
sites were located in double-stranded RNA regions
(Figure 4B) and are speciﬁed in Table 2. Figure 4A
shows the results of RNase E, RNase III and RNase T1
digestions for single-stranded and duplex RNAs of
PMM0685 in vitro-synthesized RNA. Both sense and anti-
sense RNAs of duplex RNAs had identical sizes and an
exact overlap. Incubation of single-stranded PMM0685
RNA with RNase E or RNase III yielded speciﬁc
cleavage products, whereas RNase T1, which cleaves
single-stranded RNA after guanine residues, led to
complete digestion of PMM0685 in vitro-synthesized
RNA. In contrast, the a priori duplex formation of sense
and antisense RNA before RNase E treatment prevented
RNase E digestion. RNase III treatment of duplex RNA
resulted in complete digestion of the duplex, whereas
treatment with RNase T1 did not show any cleavage
products. These ﬁndings suggest that the secondary and
tertiary structures of both RNA molecules were altered
and hybridized to each other over their full-length.
Clearly, the resultant structural changes hinder substrate
accessibility of ribonucleases that recognize single-
stranded regions (RNase E and RNase T1) and promote
enzyme activity of RNA double strand-dependent
enzymes like RNase III.
RNA duplexes that overlapped only partially with over-
hangs at the 50-o r3 0-end lead to partial degradation of
the duplex by RNase E (Figure 5). As expected, digestion
patterns indicated that double-stranded regions were
still protected, whereas single-stranded regions became
susceptible to RNase E cleavage (Figure 5). When a
3-kb polysictronic mRNA in vitro transcript was
annealed with a 3.5kb in vitro asRNA (that mimic the
in vivo transcripts) complete protection of the polycistron
after RNase E treatment was observed (Supplementary
Figure S5). The in vitro assay suggests that indeed the
3.5kb asRNA located in genomic island II is important
for the stabilization of mRNAs located opposite the
asRNA. These results suggest that complete coverage of
the mRNA by an asRNA is required to prevent RNase E
digestion. It is conceivable that the same protective mech-
anism applies for the ribosomal protein gene cluster as
the asRNA covers the complete phage induced region
(Figure 2). Therefore, complete overlap of duplex RNAs
may be a general requirement for mRNA protection.
DISCUSSION
In this study, we describe a new function for asRNA, a
class of regulatory RNA that has gained considerable at-
tention due to its recently discovered ubiquitous occur-
rence in all kingdoms of life. Previously, we (27)
suggested that the subset of host genes upregulated
during phage infection might be regulated by the phage
or might be part of a host-speciﬁc response. For either
scenario, it remained unclear how asRNAs are regulated.
A prolongation of mRNA half-life initially appeared
unlikely because RNase E expression was stimulated as
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Table 1. RNase E cleavage sites of PMM0685 in vitro transcript
Position within RNA backbone (50–30) Cleavage site (50–30)
53, 54 U_GAAAA
80, 81 AU_UACU
153, 154 AAG_CUU
162, 163 CU_CAAG
4896 Nucleic Acids Research, 2011,Vol.39, No. 11well. Here, we demonstrate the asRNA-mediated regula-
tion of RNA stability, directly inﬂuencing the half-life of
mRNAs that are protected from RNA decay by asRNAs
that completely mask RNase E recognition sites. Whether
the increase in transcript level is a ﬁnal defensive step of
the host during phage infection or whether increased
mRNA levels are supportive of viral replication [in a
similar fashion as has been suggested for phage-encoded
D1 protein (40)] remains to be investigated in future
studies. The asRNA-modulated regulation of gene expres-
sion during phage infection might be a common feature in
both the host and the phage. Millard et al. (41) reported
an asRNA that physically connects between the photosyn-
thesis gene psbA encoding the D1 core protein of photo-
system II with a homing endonuclease (F-Cphl) in the
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folded with RNAfold and drawn using VARNA. RNase E and
RNase III cleavage sites, which were deduced from northern blot hy-
bridizations with two oligonucleotide probes targeting the 50-o r3 0-end
of PMM0685 in vitro-synthesized RNA, are marked with red arrows or
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Figure 5. Ribonuclease cleavage assay of 1.3pmol single-stranded and
2.6pmol partially overlapping duplex PMM0684 in vitro-synthesized
RNAs. (A) 7M urea–6% PAA gel of PMM0684 single-stranded and
duplex in vitro RNAs (ctrl) treated with RNase E, RNase III or RNase
T1. M denotes ssRNA marker from NEB. (B) Scheme of duplex for-
mation of PMM0684 in vitro-synthesized mRNA (blue) and asRNA
(red). Regions of duplex RNA remaining after digestion with RNase
E or RNase III in (A) are labelled with corresponding numbers in (B).
Table 2. RNase III cleavage sites of PMM0685 in vitro transcript
Position within RNA
backbone (50–30)
Cleavage site (50–30)
16,17/27,28 C_C/G_G
47,48/225,226 C_A/G_U
68,69/220,221 C_A/G_U
72,73/216,217 G_A/C_U
77,78/86,87 G_C/C_G
89,90/201,202 C_U/G_A
97,98/193,194 C_G/G_U
102,103/187,188 C_A/G_U
110,111/136,137 U_A/G_U
115,116/131,132 C_A/G_U
141,142/183,184 C_U/G_G
160,161/166,167 C_C/G_G
Nucleic Acids Research, 2011,Vol.39, No. 11 4897cyanophage S-PM2. Transcripts of the asRNA as well as
of psbA and F-Cphl are induced during the lytic infection
cycle of S-PM2 in its host Synechococcus sp. WH7803.
RNase E activity is known to impact the stability of
both host and phage mRNA during infection of E. coli
by bacteriophages T7 and T4 (42,43). In both cases, the
C-terminal structural domain of RNase E is involved. For
example, the T7 protein kinase phosphorylates the struc-
tural domain of host RNase E. However, this region is not
present in the Prochlorococcus MED4 homologue.
Therefore the indirect regulation of RNase E activity in
Prochlorococcus by RNA duplex formation reported here
reﬂects an alternative mechanism of regulation of enzyme
activity that appears to be required for an organism
lacking the region modiﬁed in other host-phage systems.
Our results clearly show that the duplex RNAs resulting
from mRNA–asRNA hybridization are perfect substrates
for RNase III in vitro (Figure 4). Therefore, an interesting
question is how these duplex RNAs become protected
from RNase III degradation in vivo. Nothing is known
about RNase III protein stability in Prochlorococcus;
however, the RNase III transcript, along with the
majority of the transcriptome, is down-regulated during
phage infection (27). Furthermore, ribosome activity on
the mRNAs is likely to interfere with the full-length hy-
bridization of both transcripts in vivo. In addition, other
factors might exist in the cell that protect long duplex
complexes from degradation.
The modulation of RNase E activity by RNA–RNA
interaction has been reported before. However, base
pairing of the small regulatory RNA RyhB with the
50-UTR of sodB mRNA, changing the structure of the
mRNA leader, results in an additional RNase E
cleavage site, which in turn triggers another pathway for
sodB RNA decay (44). Hence, in this example, RNA–
RNA interaction does not hide but produces new RNase
E recognition sites. The RNase E-dependent regulation of
sodB turnover is very complex, and enzyme activity is also
inﬂuenced by RNA–protein interaction between sodB and
Hfq (an RNA chaperone that recognizes single-stranded
AU-rich regions in the same manner as RNase E). Both
RNase E and Hfq can bind mRNAs close to each other,
resulting in protection of the RNase E substrate from
nucleolytic degradation (44). Such a complex regulation
cannot be expected for Prochlorococcus MED4 because an
hfq homologue is lacking in the genome. Of the 12 com-
pletely sequenced Prochlorococcus strains, only MIT9313
and MIT9303, both belonging to the evolutionarily oldest
Prochlorococcus clade, possess an hfq homologue.
Alternatively, RNase E activity can also be inﬂuenced
by inhibitory RNase-binding proteins that dynamically
regulate RNA decay and processing. In Synechococcus
elangatus PCC 7942, the two heat shock proteins Dnak2
and DnaJ2 inhibit RNase E activity in an ATP-dependent
manner, suggesting that both proteins are involved in
RNA degradation through interaction with RNase E
(45). Both proteins are present in Prochlorococcus and
hence could provide an additional regulatory circuit for
RNA half-lives.
The reduced suite of protein regulators and the dispro-
portionately high number of regulatory RNAs in
Prochlorococcus has been linked to its adaptation to an
extremely oligotrophic habitat, combined with a
streamlined genome (37). This study provides the ﬁrst
insights into the functional role of asRNA regulators
and emphasizes the importance of this class of regulatory
molecules in the global network of gene regulation.
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Supplementary Data are available at NAR Online.
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